Simmons Chia-Lin 4
4 · Chromocell Therapeutics Corp · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Simmons Chia-Lin
Director
Transactions
- Award
Stock Option
2024-06-14+90,000→ 105,000 totalExercise: $1.30Exp: 2034-06-14→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]On June 14, 2024, the Reporting Person was granted stock options to purchase 90,000 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.